LON:SENS Sensyne Health Share Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sensyne Health PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 61.50 -1.50 (-2.38 %) (As of 09/24/2020 12:00 AM ET) Add Compare Share Today's Range 60Now: GBX 61.50▼ 62.9650-Day Range 31MA: GBX 59.07▼ 84.5052-Week Range 0.70Now: GBX 61.50▼ 132Volume45,199 shsAverage Volume265,329 shsMarket Capitalization£79.07 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsChartCompetitorsHeadlinesOptions Chain Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company's access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance. Sensyne Health is an early signatory to the Department of Health and Social Care's ‘Initial Code of Conduct for data-driven health and care technology'.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingSensyne Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 239, Sensyne Health has a forecasted upside of 288.6% from its current price of GBX 61.50.Amount of Analyst CoverageSensyne Health has only been the subject of 1 research reports in the past 90 days. Previous Next 3.9 Community Rank Outperform VotesSensyne Health has received 70 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSensyne Health has received 19 “underperform” votes. (Add your “underperform” vote.)Community SentimentSensyne Health has received 78.65% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Sensyne Health and other stocks. Vote “Outperform” if you believe SENS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SENS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSensyne Health does not currently pay a dividend.Dividend GrowthSensyne Health does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sensyne Health insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Sensyne Health is -4.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sensyne Health is -4.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSensyne Health has a P/B Ratio of 1.42. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.48 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Health Information Services Sub-IndustryN/A SectorComputer and Technology Current SymbolLON:SENS Previous Symbol CUSIPN/A CIKN/A Webwww.sensynehealth.com Phone44 3300 581845Debt Debt-to-Equity Ratio3.88 Current Ratio10.89 Quick Ratio10.70Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£489,000.00 Price / Sales161.70 Cash FlowGBX 27.28 per share Price / Cash Flow2.25 Book ValueGBX 43.40 per share Price / Book1.42Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees70 Outstanding Shares128,572,000Market Cap£79.07 million Next Earnings DateN/A OptionableOptionable GBX 61.50 -1.50 (-2.38 %) (As of 09/24/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive SENS News and Ratings via Email Sign-up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter. Sensyne Health (LON:SENS) Frequently Asked Questions How has Sensyne Health's stock been impacted by Coronavirus? Sensyne Health's stock was trading at GBX 39 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SENS shares have increased by 57.7% and is now trading at GBX 61.50. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Sensyne Health? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensyne Health in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Sensyne Health. What price target have analysts set for SENS? 3 brokers have issued 1-year price targets for Sensyne Health's stock. Their forecasts range from GBX 195 to GBX 262. On average, they anticipate Sensyne Health's share price to reach GBX 239 in the next year. This suggests a possible upside of 288.6% from the stock's current price. View analysts' price targets for Sensyne Health. Who are some of Sensyne Health's key competitors? Some companies that are related to Sensyne Health include Kneat.com (KSI), Vitalhub (VHI), Reliq Health Technologies (RHT), Induction Healthcare Group (INHC), Diagnos (ADK), CardioComm Solutions (EKG), 1ST Group (1ST), Alcidion Group (ALC), CannaOne Technologies (CNONF), CannaOne Technologies (CNNA), CloudMD Software & Services (DOC), CloudMD Software & Services (DOCRF), CogState (CGS), CompuMed (CMPD) and Corum Group (COO). View all competitors. What other stocks do shareholders of Sensyne Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sensyne Health investors own include Fresenius Medical Care AG & Co. KGaA (FME), Green Plains Partners (GPP), Hershey (HSY), Gilead Sciences (GILD), Griffon (GFF), Emerald Expositions Events (EEX), DHX Media (DHXM), Ctrip.Com International (CTRP), Corus Entertainment (CJR) and Citizens Financial Group (CFG). What is Sensyne Health's stock symbol? Sensyne Health trades on the London Stock Exchange (LON) under the ticker symbol "SENS." How do I buy shares of Sensyne Health? Shares of SENS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Sensyne Health's stock price today? One share of SENS stock can currently be purchased for approximately GBX 61.50. How big of a company is Sensyne Health? Sensyne Health has a market capitalization of £79.07 million and generates £489,000.00 in revenue each year. Sensyne Health employs 70 workers across the globe. What is Sensyne Health's official website? The official website for Sensyne Health is www.sensynehealth.com. How can I contact Sensyne Health? The company can be reached via phone at 44 3300 581845. This page was last updated on 9/25/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
